Photo of Andrew Woo
  • The University of Western Australia (M519), 35 Stirling Highway,

    6009 Perth

    Australia

  • 864 Citations
  • 11 h-Index
20022019
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Andrew J. Woo completed his Bachelor of Science with Honours and a Doctor of Philosophy in Biochemistry at The University of Western Australia in 2004. He then began his postdoctoral training under Dr. Alan B. Cantor’s mentorship at Children’s Hospital Boston / Dana-Faber Cancer Institute at Harvard Medical School, Boston, USA. Transcriptional gene regulation is the focus of his research and his discoveries contributed to the study of blood disorders, cancer and stem cell biology. He has published in many prestigious journals including, Cell, Journal of Clinical Investigation, Molecular Cell, Genes and Development, Nature Communications, Blood and Molecular & Cellular Biology. He has returned to Perth in 2012 with a fellowship from Royal Perth Hospital Medical Research Foundation.

Roles and responsibilities

Research approaches include.
- Protein-Protein Interaction identification via proteomics
- Protein-DNA interaction mapping via next generation sequencing techniques
- Transcriptomics by next generation sequencing techniques
- Functional genomics
- Transgenic Mouse Models

Funding overview

2015 CIA, Cancer Council of Western Australia, Perth, Australia
2015 Sole CI, Medical Research Foundation WA, Perth, Australia
2014 Sole CI, Medical Research Foundation WA, Perth, Australia
2013 Sole CI, Medical Research Foundation WA, Perth, Australia
2012 Fellowship, Medical Research Foundation WA, Perth, Australia

Previous positions

Postdoctoral Research Fellow
Department of Hematology and Oncology
Boston Children's Hospital / Dana-Farber Cancer Institute,
Harvard Medical School,
Boston, MA, USA.

Research

Dr Andrew Woo’s research interests encompass understanding the transcriptional gene regulatory mechanisms in stem/progenitors cells of blood and epithelial cancer stem cells. With Dr. Peter Leedman at Harry Perkins Institute of Medical Research, he also investigates the role of small non-coding RNA processing complexes in epithelial cancer onset and metastasis.

Languages

English and Korean

External positions

Sessional Lecturer, Edith Cowan University

1 Jul 201828 Feb 2020

Keywords

  • Transcriptional gene regulation
  • Stem cells and cancer
  • Haematopoiesis and blood disorders
  • Hormone-dependent cancers
  • Protein-protein interaction
  • Protein-DNA interaction
  • Mouse genetics
  • Bioinformatics

Fingerprint Dive into the research topics where Andrew Woo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Transcription Factors Medicine & Life Sciences
Polycomb Repressive Complex 1 Medicine & Life Sciences
Genes Medicine & Life Sciences
Regulator Genes Medicine & Life Sciences
Histone Demethylases Medicine & Life Sciences
Gene expression Chemical Compounds
Core Binding Factors Medicine & Life Sciences
Yin-Yang Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 864 Citations
  • 11 h-Index
  • 15 Article
  • 2 Abstract/Meeting Abstract
  • 1 Comment/debate
  • 1 Doctoral Thesis
1 Citation (Scopus)

JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis

Lynch, J. R., Salik, B., Connerty, P., Vick, B., Leung, H., Pijning, A., Jeremias, I., Spiekermann, K., Trahair, T., Liu, T., Haber, M., Norris, M. D., Woo, A. J., Hogg, P., Wang, J. & Wang, J. Y., 8 Jan 2019, In : Leukemia. 33, 6, p. 1400-1410 11 p.

Research output: Contribution to journalArticle

Homeobox Genes
Acute Myeloid Leukemia
Heterografts
Stem Cells
Oxidative Phosphorylation

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia

Gonzales-Aloy, E., Connerty, P., Salik, B., Liu, B., Woo, A. J., Haber, M., Norris, M. D., Wang, J. & Wang, J. Y., Jul 2019, In : Haematologica. 104, 7, p. e296-e299

Research output: Contribution to journalArticle

Open Access

Zfp281 (ZBP-99) Plays a Functionally Redundant Role with Zfp148 (ZBP-89) during Erythroid Development

Woo, A., 12 Jun 2019, (Accepted/In press) In : Blood advances.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers

Wang, E., Sorolla, A., Cunningham, P. T., Bogdawa, H. M., Beck, S., Golden, E., Dewhurst, R. E., Florez, L., Cruickshank, M. N., Hoffmann, K., Hopkins, R. M., Kim, J., Woo, A. J., Watt, P. M. & Blancafort, P., 3 Aug 2018, In : Oncogene. 38, 1, p. 140-150

Research output: Contribution to journalComment/debate

Open Access
Triple Negative Breast Neoplasms
Peptides
Neoplasms
Cell Fusion
Gene Expression Profiling

Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer

Redfern, A., Rashwan, R., Sorolla, A., Ratajska, M., Kardas, I., Kuzniacka, A., Parry, J., Curtis, C., Woo, A., Sgro, A. & Biernat, W., 15 Feb 2016, In : Cancer Research. 76, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Projects 2012 2019

Prizes